Pharmaceutical Sources

Latest News for: Pharmaceutical sources

Edit

Vertex Appoints Lloyd Carney to its Board of Directors

Citizen Tribune 22 Feb 2019

BOSTON--(BUSINESS WIRE)--Feb 21, 2019--Vertex Pharmaceuticals Incorporated (Nasdaq ... Mr ... The addition of Mr ... Previously, Mr ... Mr ... Mr ... (VRTX-GEN). View source version on businesswire.com.https.//www.businesswire.com/news/home/20190221005847/en/ ... Vertex Pharmaceuticals Incorporated ... HEALTH BIOTECHNOLOGY PHARMACEUTICAL. SOURCE. Vertex Pharmaceuticals Incorporated....

Edit

CORRECTING and REPLACING NanoSphere Closes $2 Million Private Placement Offering

SCNOW Morning News 22 Feb 2019

NanoSphere Health Sciences LLC, is a biotechnology firm specializing in the creation of the NanoSphere Delivery System™, a revolutionary platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries ... SOURCE....

Edit

IGC Announces Successful Appeal of Delisting Proceedings and Imminent Relisting on NYSE American

Odessa American 22 Feb 2019

BETHESDA, Md.--(BUSINESS WIRE)--Feb 21, 2019--India Globalization Capital, Inc. (NYSE American. IGC; PINK ... About IGC.. IGC has two lines of business ... The company is based in Maryland, U.S.A. Our website ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20190221006070/en/ ... HEALTH ALTERNATIVE MEDICINE PHARMACEUTICAL. SOURCE ... PUB....

Edit

Moderna to Report Fourth Quarter and Full Year 2018 Financial Results on Wednesday, March 6, 2019

Odessa American 22 Feb 2019

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 21, 2019--Moderna, Inc., (Nasdaq ... ET on Wednesday, March 6, 2019 to report its fourth quarter and full year 2018 financial results and provide a corporate update ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20190221005753/en/. CONTACT ... HEALTH BIOTECHNOLOGY PHARMACEUTICAL. SOURCE....

Edit

bluebird bio Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Operational Progress

Citizen Tribune 22 Feb 2019

The increase in cash, cash equivalents and marketable securities is primarily related to the completion of a public offering of common stock in July 2018, which raised net proceeds of approximately $600.6 million, the receipt of a $100.0 million investment from Regeneron Pharmaceuticals, Inc ... SOURCE....

Edit

Ra Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference

Waco Tribune-Herald 21 Feb 2019

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 21, 2019--Ra Pharmaceuticals, Inc ... About Ra Pharmaceuticals. Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases ... Ra Pharmaceuticals ... HEALTH BIOTECHNOLOGY PHARMACEUTICAL RESEARCH SCIENCE MANAGED CARE. SOURCE....

Edit

Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2018 Financial Results Conference Call

Waco Tribune-Herald 21 Feb 2019

HENDERSON, Nev.--(BUSINESS WIRE)--Feb 21, 2019--Spectrum Pharmaceuticals (NasdaqGS ... Listeners may access the webcast, which will be available on the investor relations page of Spectrum Pharmaceuticals' website ... About Spectrum Pharmaceuticals, Inc ... © 2019 Spectrum Pharmaceuticals, Inc.All Rights Reserved ... HEALTH BIOTECHNOLOGY ONCOLOGY PHARMACEUTICAL....

Edit

Nexus Pharmaceuticals Receives FDA Approval for Prochlorperazine Edisylate Injection, USP

Market Watch 21 Feb 2019

Nexus Pharmaceuticals announced today it has received U.S ... “The launch further expands our generic injectable portfolio but more importantly, it shows our commitment to meeting the increased market demand of generic injectables and mitigate the risk of future drug shortages,” said Omair Ahmed, Chief Commercial Officer of Nexus Pharmaceuticals....

Edit

Aurinia to Present at the 8th Annual SVB Leerink Global Healthcare Conference New York City

SCNOW Morning News 21 Feb 2019

VICTORIA, British Columbia--(BUSINESS WIRE)--Feb 20, 2019--Aurinia Pharmaceuticals Inc., (NASDAQ.AUPH)(TSX.AUP) today announced its Chairman and Chief Executive Officer, Richard M ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20190220005840/en/ ... HEALTH BIOTECHNOLOGY PHARMACEUTICAL. SOURCE. Aurinia Pharmaceuticals Inc....

Edit

Alexion to Present at the 8th Annual SVB Leerink Global Healthcare Conference

Market Watch 21 Feb 2019

Alexion Pharmaceuticals ALXN, -1.76% today announced that management will ... View source version on businesswire.com ... SOURCE. Alexion Pharmaceuticals....

Edit

West Announces Quarterly Dividend and Share Repurchase Program

The Record 21 Feb 2019

21, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc ... About West West Pharmaceutical Services, Inc ... Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply ... SOURCE West Pharmaceutical Services, Inc....

Edit

Dicerna Bolsters Leadership Team to Support Continued Growth

Market Watch 21 Feb 2019

Dicerna Pharmaceuticals, Inc ... Most recently, she was senior vice president of human resources at Paratek Pharmaceuticals, reporting directly to the chief executive officer and chairman as a member of the executive leadership team ... She has also held several executive positions in human resources at Sepracor Pharmaceuticals and Tufts Health Plans....

Edit